A missense mutation in the 3-ketodihydrosphingosine reductase FVT1 as candidate causal mutation for bovine spinal muscular atrophy
- 17 April 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (16) , 6746-6751
- https://doi.org/10.1073/pnas.0607721104
Abstract
The bovine form of the autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) shows striking similarity to the human form of the disease. It has, however, been mapped to a genomic region not harboring the bovine orthologue of the SMN gene, mutation of which causes human SMA. After refinement of the mapping results we analyzed positional and functional candidate genes. One of three candidate genes, FVT1, encoding 3-ketodihydrosphingosine reductase, which catalyzes a crucial step in the glycosphingolipid metabolism, showed a G-to-A missense mutation that changes Ala-175 to Thr. The identified mutation is limited to SMA-affected animals and carriers and always appears in context of the founder haplotype. The Ala variant found in healthy animals showed the expected 3-ketodihydrosphingosine reductase activity in an in vitro enzyme assay. Importantly, the Thr variant found in SMA animals showed no detectable activity. Surprisingly, in an in vivo assay the mutated gene complements the growth defect of a homologous yeast knockout strain as well as the healthy variant. This finding explains the viability of affected newborn calves and the later neuron-specific onset of the disease, which might be due to the high sensitivity of these neurons to changes in housekeeping functions. Taken together, the described mutation in FVT1 is a strong candidate for causality of SMA in cattle. This result provides an animal model for understanding the underlying mechanisms of the development of SMA and will allow efficient selection against the disease in cattle.Keywords
This publication has 31 references indexed in Scilit:
- Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative diseaseHuman Molecular Genetics, 2006
- Oxysterol-binding Protein and Vesicle-associated Membrane Protein–associated Protein Are Required for Sterol-dependent Activation of the Ceramide Transport ProteinMolecular Biology of the Cell, 2006
- A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral SclerosisAmerican Journal of Human Genetics, 2004
- FVT-1 Is a Mammalian 3-Ketodihydrosphingosine Reductase with an Active Site That Faces the Cytosolic Side of the Endoplasmic Reticulum MembraneJournal of Biological Chemistry, 2004
- Ceramidase Regulates Synaptic Vesicle Exocytosis and TraffickingJournal of Neuroscience, 2004
- Membrane dynamics and cell polarity: the role of sphingolipidsJournal of Lipid Research, 2003
- Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruptionBiochemical Society Transactions, 2001
- Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruptionBiochemical Society Transactions, 2001
- Spinal Muscular Atrophy in Brown Swiss CalvesJournal of Veterinary Medicine Series A, 1989
- Juvenile spinal muscular atrophy: A new hexosaminidase deficiency phenotypeAnnals of Neurology, 1982